A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin

Transfusion and Apheresis Science

Volumn 35, Issue 2, 2006, Pages 131-136

  Palfi, Miodrag ^a   Hildén, Jan Olof ^a   Matthiesen, Leif ^a   Selbing, Anders ^a   Berlin, Gösta ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIBODY;

ADULT; ALLOIMMUNIZATION; APGAR SCORE; ARTICLE; BIRTH; BODY WEIGHT; CASE REPORT; CONVALESCENCE; ECHOGRAPHY; EXCHANGE BLOOD TRANSFUSION; FEMALE; FETUS DEATH; FETUS HYDROPS; HOSPITAL ADMISSION; HUMAN; INDUCED ABORTION; INTRAUTERINE BLOOD TRANSFUSION; MALE; NEWBORN; PHOTOTHERAPY; PLASMAPHERESIS; PREGNANCY; PREGNANCY TERMINATION;

CESAREAN SECTION; FEMALE; HUMANS; HYDROPS FETALIS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; LIVE BIRTH; MALE; PLASMA EXCHANGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN; SEVERITY OF ILLNESS INDEX;

EID: 33751239457     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2006.07.002     Document Type: Article

References (28)

1. Bowman J.M. Intrauterine transfusion. In: Anderson K.C., and Ness P.M. (Eds). Scientific basis of transfusion medicine. Implications for clinical practice (1994), WB Saunders, Philadelphia 403-420
2. Berlin G., Selbing A., and Ryden G. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin. Lancet 1 8438 (1985) 1153
3. Fernandez-Jimenez M.C., Jimenez-Marco M.T., Hernandez D., Gonzalez A., Omenaca F., and de la Camara C. Treatment with PE and intravenous immunoglobulin in pregnancies complicated with anti-PP1Pk or anti-K immunization: a report of two patients. Vox Sang 80 2 (2001) 117-120
4. Haentjens-Verbeke K., Dufour P., Vinatier D., Tordjeman N., Monnier J.C., and Manessier L. Anti-Tja alloimmunization (anti-PP1Pk): two consecutive pregnancies of an anti-Tja-carrying patient. Fetal Diagn Ther 11 2 (1996) 120-125
5. Berlin G., Selbing A., and Gottvall T. Plasma exchange and intravenous immunoglobulin treatment of the mother to diminish fetal Rhesus hemolytic disease. Transf Sci 11 (1990) 85-90
6. Porter T.F., Silver R.M., Jackson G.M., Branch D.W., and Scott J.R. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv 52 3 (1997) 193-197
7. Margulies M., Voto L.S., Mathet E., and Margulies M. High-dose intravenous IgG for the treatment of severe Rhesus alloimmunization. Vox Sang 61 3 (1991) 181-189
8. Gottvall T., and Selbing A. Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus. Acta Obstet Gynecol Scand 74 10 (1995) 777-783
9. Lapierre Y., Rigal D., Adam J., Josef D., Meyer F., Greber S., et al. The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 30 2 (1990) 109-113
10. Hilden J.O., Backteman K., Nilsson J., and Ernerudh J. Flow-cytometric quantitation of anti-D antibodies. Vox Sang 72 3 (1997) 172-176
11. Palfi M., and Hilden J.O. Application of the gel test in IgG subclassing - a comparison of two agglutination assays. Vox Sang 72 2 (1997) 114-117
12. Shechter Y., Timor-Tritsch I.E., Lewit N., Sela R., and Levene C. Early treatment by PE in a woman with multiple abortions and the rare blood group p. Vox Sang 53 3 (1987) 135-138
13. Gravenhorst J.B. Management of serious alloimmunization in pregnancy. Vox Sang 55 (1988) 1-8
14. Gottvall T., Hilden J.O., and Selbing A. Evaluation of standard parameters to predict exchange transfusions in the erythroblastotic newborn. Acta Obstet Gynecol Scand 73 4 (1994) 300-306
15. Nicolaides K.H., and Rodeck C.H. Maternal serum anti-D antibody concentration and assessment of Rhesus isoimmunisation. BMJ 304 6835 (1992) 1155-1156
16. Bowman J.M. Treatment options for the fetus with alloimmune hemolytic disease. Transf Med Rev 3 (1990) 191-207
17. Palfi M., and Selbing A. Placental transport of maternal immunoglobulin G. Am J Reprod Immunol 39 1 (1998) 24-26
18. Grozdea J., Brisson-Lougarre A., Vergnes H., Bierme R., Alie-Daram S., Martin J., et al. IgG/placental alkaline phosphatase complexes in Rh-incompatible pregnancy with fetal hydrops. Vox Sang 55 1 (1988) 42-43
19. Brisson-Lougarre A., Vergnes H., Grozdea J., Alie-Daram S., Fontanilles A.M., and Bierme R. New antibody in severe rhesus incompatible pregnancies: IgG-kappa antiplacental alkaline phosphatase. Am J Reprod Immunol 19 4 (1989) 151-154
20. Hilden J.O., Gottvall T., and Lindblom B. HLA phenotypes and severe Rh (D) immunization. Tissue Antigens 46 4 (1995) 313-315
21. Ulm B., Svolba G., Ulm M.R., Bernaschek G., and Panzer S. Male fetuses are particularly affected by maternal alloalloimmunization to D antigen. Transfusion 39 2 (1999) 169-173
22. Urbaniak S.J., Duncan J.I., Armstrong-Fisher S.S., Abramovich D.R., and Page K.R. Transfer of anti-D antibodies across the isolated perfused human placental lobule and inhibition by high-dose intravenous immunoglobulin: a possible mechanism of action. Br J Haematol 96 1 (1997) 186-193
23. Clynes R. Immune complexes as therapy for autoimmunity. J Clin Invest 115 1 (2005) 25-27
24. Yu Z., and Lennon V.A. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 340 3 (1999) 227-228
25. Dooren M.C., van Kamp I.L., Scherpenisse J.W., Brand R., Ouwehand W.H., Kanhai H.H., et al. No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease. Vox Sang 66 4 (1994) 253-257
26. Nydegger U.E., Mohacsi P.J., Escher R., and Morell A. Clinical use of intravenous immunoglobulins. Vox Sang 78 Suppl 2 (2000) 191-195
27. Thilaganthan B., Nicolaides K.H., and Morgan G. Intrauterine bone-marrow transplantation at 12 weeks' gestation. Lancet 342 8865 (1993) 243
28. Hayward A., Ambruso D., Battaglia F., Donlon T., Eddelman K., Giller R., et al. Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn Ther 13 1 (1998) 8-14